BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.02
+0.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.73x
- Price / sales
- 8.45x
- Price / cash flow
- -1.24x
Enterprise value
- Enterprise value
- $7.8M
- EV / sales
- 6.53x
- EV / EBITDA
- -34.56x
- EV / EBIT
- -0.75x
- Market cap
- $10.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026